Targeted therapy in bone and soft tissue sarcoma in children and adolescents. - Wikidata - wikimedia - TriplyDB

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

http://www.wikidata.org/entity/Q37981129

about

Cellular immunotherapy for pediatric solid tumors Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.The future of immunotherapy for sarcoma.Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?Peptide vaccination therapy: Towards the next generation.Survivin and vascular endothelial growth factor are associated with spontaneous pulmonary metastasis of osteosarcoma: Development of an orthotopic mouse model.Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

P2860

Q27014912-5C68E29C-A0C2-456E-802D-95ACE4984AEA Q28485467-21AC6112-56BE-49C8-9377-ABA093F3649D Q33439510-128803DF-C238-4687-BE70-D9072025E22D Q37018237-26512EF4-2D90-4C4A-8FD3-1B16531E9EBF Q38829558-E4726349-6282-4390-9FE1-F13E36B99266 Q38843229-62F2F611-8B66-429E-8EF8-A764349A3504 Q38902336-C8E88259-83FB-4805-ACC7-117C7D52C7B6 Q42968843-9D3DBF10-E1A1-4718-9EE6-1F461EDA7042 Q51738705-CB5377B7-5A3C-4EAF-B389-465741474B1E Q58566155-68B65A52-CFAD-413C-8181-1FBDDD2C9894

P2860

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

http://www.wikidata.org/entity/Q37981129

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@en

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@nl

type

label

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@en

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@nl

prefLabel

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@en

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@nl

P1433

Q37981129-795FAEBF-5A9C-48DB-A1EC-7E0332F7A93A

P1476

Q37981129-89E2F22C-3F3F-4221-99D5-E9B1307D2047

P2093

Q37981129-C8343D89-618D-493E-866E-0706E0818724

Q37981129-EF6A7F1F-4B12-4B1D-ADE4-CB6899BB905B

P2860

Q37981129-0C048150-D113-47E1-86A3-8066E533F76B

Q37981129-0CF60ECA-A241-43C4-94C3-DE0F06FBE93A

Q37981129-136E89EA-ED51-47A7-AA0A-277CB6D4BBE3

Q37981129-21AABA9A-49E4-4341-9156-9D072E9E9396

Q37981129-25764A7F-8F76-482C-82AB-F2DDF2AB2190

Q37981129-2606E473-7D67-43B6-87D7-1174E654F9CB

Q37981129-27B4AF3A-4B06-48FF-9FD1-6F032A9114A1

Q37981129-2C60BCDB-F845-4F06-9D7E-5DB0554A2255

Q37981129-3C7C7E5C-0561-4E6D-B27D-8435F97B6890

Q37981129-4BDEED40-8DCA-4C20-A589-2A6D130C16D4

P2888

Q37981129-B61D296A-FCD3-4322-BBF7-1B402A2D0E67

P304

Q37981129-BB3A928E-C990-44F3-941E-494A3F12C9DA

P31

Q37981129-5B4407A9-70F6-48C3-B1FB-6C4B63AC87EC

P356

Q37981129-92D7D30A-EC28-4138-B1C8-A6C600149CD6

P433

Q37981129-CFDBF2F1-4F13-4448-AC55-B8B7D604DC8B

P478

Q37981129-402EA47A-2CD1-4F0F-B1ED-0958192E0E23

P50

Q37981129-1A339A6A-C50C-493F-91E4-1116D021C8B6

P577

Q37981129-48DAF7D9-8C04-42FF-BD3F-90AD102BD694

P698

Q37981129-8E3AEDAE-F8DB-4237-AB37-190D5AA1B77A

P921

Q37981129-2E4C3A14-2B78-4352-B565-8689EDF0455E

P356

S11912-012-0223-2

P1433

Current Oncology Reports

P1476

Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

@en

P2093

Murali Chintagumpala

http://www.w3.org/2001/XMLSchema#string

Patrick A Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma

MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development

CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways.

Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family.

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

Biology of EWS/ETS fusions in Ewing's family tumors.

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT).

P2888

s11912-012-0223-2

P304

197-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-012-0223-2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Murali Chintagumpala

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22302601

http://www.w3.org/2001/XMLSchema#string

P921